The rs4251545 polymorphisms of IRAK4 (p.Ala428Thr) were reported to modify susceptibility to hepatitis B virus (HBV)-related HCC via increased proliferation and reduced production of inflammatory cytokines and chemokines [51]. Here, IRAK4 is linked to hepatocellular carcinoma.